<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The term epigenetics refers to the heritable changes in gene expression that do not represent changes in DNA sequence </plain></SENT>
<SENT sid="1" pm="."><plain>DNA methylation and <z:chebi fb="0" ids="15358">histone</z:chebi> modification are the best studied epigenetic mechanisms </plain></SENT>
<SENT sid="2" pm="."><plain>However, microRNAs, which affect gene expression at the posttranscriptional level, should be considered as members of the epigenetic machinery too </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are clone disorders of the hematopoietic stem cell with increased risk of leukemic transformation </plain></SENT>
<SENT sid="4" pm="."><plain>Over the years, increased number of studies indicates the role of epigenetic mechanisms, including microRNAs, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> pathogenesis and prognosis </plain></SENT>
<SENT sid="5" pm="."><plain>Indeed, epigenetic therapy with demethylating agents has already been applied to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In this review we summarize current knowledge on the role of epigenetic alterations in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> pathogenesis and treatment </plain></SENT>
</text></document>